Letters to the Editor
Finding independent information on new drugs
- A M Tejani
- Aust Prescr 2011;34:85-8
- 1 October 2011
- DOI: 10.18773/austprescr.2011.068
Editor, – I read the article by Rosalind Tindale with great interest (Aust Prescr 2011;34:85-8). She lists some great resources and the compilation will be very useful for me.
I would like to suggest the Therapeutics Initiative (www.ti.ubc.ca) as an additional resource for independent, critical evaluation of evidence for drugs. All information is currently free of charge.
Research assistant, Therapeutics Initiative
Editorial note: Like Australian Prescriber, Therapeutics Initiative is a member of the International Society of Drug Bulletins.
The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Research assistant, Therapeutics Initiative Canada